The Global Biotech & Pharma Patent (China) Summit 2026 will bring together leading pharmaceutical companies, biotech firms, research institutions, law firms, intellectual property agencies, and industry experts from around the world. Centered on the core theme of "Focus on APAC Global Vision,Guided by Insight, Innovation Without Borders," and the summit will delve into patent strategies for cutting-edge technologies, global patent deployment and management, cross-border licensing and collaboration, as well as the latest trends in policies and ethics.We are in an era of global health revolution driven by biotechnological innovation. From gene editing to AI-driven drug discovery, disruptive technologies are redefining pharmaceutical R&D. In this process, intellectual property—particularly patents—serves not only as a legal shield but also as a core strategic asset determining the value of technology transfer and global collaboration.China has emerged as an indispensable presence in this landscape. With substantial R&D investment and a maturing ecosystem, it has transitioned from a "fast follower" to a "parallel leader," contributing original achievements across multiple fields while deepening global collaboration.However, the global patent landscape is increasingly complex, with regional differences in examination, cross-border enforcement challenges, and new models like open-source licensing. These demand more sophisticated IP strategies. Key questions now are: How to build a patent system combining international vision with local expertise? How to accelerate innovation through strategic IP management? The answers will determine the biopharmaceutical industry's success in the coming decade. These points are precisely part of the original intent behind hosting this summit and part of the key topics to be discussed with relevant professionals. Join us on Jun 4th-5th! Register now to reserve your place at this exclusive event. Agenda Overview: Day 1 Morning:The integration and challenges of regulatory science and the patent systemü Latest Practices and Future Prospects of Drug Data Protection and Market Exclusivity Systemsü How to Optimize Application Strategies and Quality Management of Biopharmaceutical Patents under the Fast-Track Patent Examination Systemü Patent Challenges in the ADC/Bispecific Antibody 2.0 Eraü A New Balance Under Global Competition and Cooperation: Challenges, Evolution, and Multinational Corporate Strategies of Biopharmaceutical Patent Linkage SystemsDay 1 Afternoon:Maximizing Patent Value and New Commercialization Modelsü Biosimilar Patent Challenge Strategies and Patent Cliff Managementü Patent Due Diligence and Investment Risksü Trade Secrets vs. Patent Trademarks: Biopharmaceutical Innovation Protection Strategies in High-Risk Litigationü Maximizing Innovation Value Using a Composite Intellectual Property Strategy (Patent + Data Protection)ü Intellectual Property Risks and Management in the Context of Supply Chain Restructuring and Digital Therapy ComplianceDay 2 Morning:Global Perspective on Biopharmaceutical R&D and Patent Strategies and Competitionü How to Develop Differentiated Claim Strategies to Cope with Strict Inventiveness/Obviousness Examinations in Various Countriesü Patent Issues and Intellectual Property Risk Prevention in Cross-Border Biopharmaceutical Collaborationü Patent Layout and Cross-Border Expansion Strategies for Pharmaceutical Companiesü Patent Issues in Cross-Border Biopharmaceutical Collaboration and Strategies for Protecting Pharmaceutical Intellectual PropertyDay 2 Afternoon:Opportunities and Legal Challenges of AI in Biotechnology and Pharmaceutical Intellectual Propertyü Patent Challenges and Strategies for AI-Driven Drug Discovery, Gene Editing, and Cell and Gene Therapyü Patent Eligibility and Data Protection in AI-Driven Drug Developmentü Balance and Development of Innovative and Generic Drugs under the Drug Patent Linkage Systemü Deep Integration of AI in Drug Development and Intellectual Property Protection Strategies More details about the topics, please find attached agenda. Partial inviting Companies & Institutions : CNIPAEUIPOWIPOPhIRDAEli Lilly and CompanyNovo NordiskJohnson & JohnsonAbbVieMerck Sharp & DohmeRocheAstraZenecaNovartisPfizerAmgenSanofiGileadSciencesBristol-Myers SquibbVertex PharmaceuticalsRegeneron PharmaceuticalsNovo NordiskChugai PharmaceuticalGSKMerck KGaASun PharmaceuticalCVS HealthDaiichi SankyōLONZATakeda PharmaceuticalHengrui PharmaceuticalsUCBArgenxAlnylam Pharmaceuticals IncCelltrionOtsuka HoldingsGalderma GroupTEVAWuXi AppTecWest PharmaceuticalBeiGeneBiogen IncLabCorpBayerDivis LaboratoriesSandozICONAstellas PharmaModernaBaxterNeurocrine BiosciencesCipla Ltd.,ViatrisHansoh PharmDr. Reddy'sLupin LimitedServierIncyte, CorpGenmabEisaiLuoxin Pharmaceutical GroupCSPC PharmaTide PharmaceuticalBRILLIANT PHARMACEUTICALInnovent BiologicsBio-Thera SolutionsSalubris PharmaceuticalsHaiscom pharmaceuticalEaston BiopharmaceuticalsHua MedicineGenscript CorporationTransThera BiosciencesCHIPSCREEN BIOSCIENCESHumanwell PharmaceuticalFosun Kite BiotechnologyHybio PharmaceuticalAllist PharmaceuticalsXiangxue Life SciencesHumanwell HealthcareXuanZhu PharmaStaidsonShineway PharmaceuticalKanghong PharmaceuticalI-Mab BiopharmaCRDCNew Era PharmaceuticalAscentage PharmaARSUAMOONJiangxi Jemincare GroupYangzijiang PharmaceuticalLintonPharm Co., Ltd.Grand PharmaceuticalQilu PharmaceuticalShanghai PharmaceuticalsKelun PharmaceuticalBuchang PharmaceuticalsLivzon PharmaceuticalSunshineLakeHuahai PharmaceuticalConba Pharmaceutical3SBio Inc.Jiuzhou PharmaceuticalHisun PharmaceuticalSimcere PharmaceuticalBeijing Intellectual Property CourtShanghai Technology ExchangeNhwa Pharmaceutical Tongyuankang PharmaceuticalKangma BiotechnologyRege BiotechZhejiang BaiChengPharmaceuticalTongji UniversityHitGen Inc.Impact TherapeuticsHutchison China MediTechCR Double CraneSinocelltech Gendicine BiopharmaceuticalShenyang Xingqi PharmaceuticalImpact TherapeuticsAsieris PharmaceuticalsMetseraLaNova MedicinesInnolake BiopharmChengdu Guowei BiologicalRibo Life Science Johnson & Johnson MedTechAdlai NortyeKejun PharmaceuticalBeijing Wuhe Boao PharmaceuticalYoujia (Hangzhou) BiotechnologyLyvgen BiopharmaMabwell (Shanghai) BioscienceIASO BioTOT BiopharmSuzhou Gelanke PharmaceuticalBioNTechSanegeneBioMedical Academy of Sciences & ResearchKangbaida (Sichuan) BiologicalShanghai Luoqi BiotechnologyYuekang Kechuang PharmaceuticalSunshineLakeKelun-Bota BiotechChina Biologic ProductsJunhemeng BiotechXiamen Amoytop BiotechYuansong BiotechnologyWuXi BiologicsJ Xinnian PharmaceuticalShanghai Yunsheng Yanxin BiotechSimcere Pharmaceuticalwebsite://en.zvuaz.cn/p/1176775/
引(yin)言(yan)隨著汽(qi)車(che)(che)(che)(che)(che)產(chan)(chan)(chan)(chan)業(ye)向“新(xin)(xin)(xin)四化(hua)(hua)”(電(dian)(dian)(dian)(dian)(dian)動(dong)(dong)化(hua)(hua)、智能(neng)(neng)化(hua)(hua)、網聯化(hua)(hua)、共(gong)享(xiang)化(hua)(hua))深(shen)度轉型(xing)(xing)(xing),其(qi)(qi)(qi)(qi)(qi)競(jing)(jing)爭(zheng)(zheng)(zheng)核(he)心已(yi)從傳(chuan)統(tong)的(de)(de)(de)(de)(de)(de)(de)(de)機(ji)械制(zhi)造(zao)轉變(bian)為(wei)(wei)(wei)(wei)芯片、軟(ruan)件(jian)(jian)(jian)、電(dian)(dian)(dian)(dian)(dian)池(chi)(chi)(chi)技(ji)(ji)(ji)術(shu)(shu)(shu)和(he)智能(neng)(neng)算(suan)法(fa)(fa)(fa)(fa)(fa)的(de)(de)(de)(de)(de)(de)(de)(de)比(bi)拼。這(zhe)(zhe)使(shi)得知識產(chan)(chan)(chan)(chan)權(quan)(quan)(quan)(IP)成(cheng)(cheng)(cheng)(cheng)(cheng)(cheng)(cheng)(cheng)為(wei)(wei)(wei)(wei)車(che)(che)(che)(che)(che)企(qi)(qi)(qi)*關(guan)(guan)鍵(jian)的(de)(de)(de)(de)(de)(de)(de)(de)資產(chan)(chan)(chan)(chan)和(he)護(hu)城河,同時(shi)也引(yin)發(fa)(fa)了(le)全(quan)(quan)球范(fan)圍內(nei)日(ri)(ri)(ri)益頻繁且復雜的(de)(de)(de)(de)(de)(de)(de)(de)知識產(chan)(chan)(chan)(chan)權(quan)(quan)(quan)糾(jiu)(jiu)(jiu)紛(fen)(fen)(fen)。本(ben)(ben)案(an)(an)(an)(an)(an)例(li)集收(shou)錄了(le)2020年(nian)(nian)(nian)(nian)(nian)至2025年(nian)(nian)(nian)(nian)(nian)間(jian)具有(you)(you)代表(biao)性(xing)(xing)的(de)(de)(de)(de)(de)(de)(de)(de)全(quan)(quan)球汽(qi)車(che)(che)(che)(che)(che)IP糾(jiu)(jiu)(jiu)紛(fen)(fen)(fen)案(an)(an)(an)(an)(an)例(li)。一、 電(dian)(dian)(dian)(dian)(dian)池(chi)(chi)(chi)技(ji)(ji)(ji)術(shu)(shu)(shu)與(yu)(yu)(yu)電(dian)(dian)(dian)(dian)(dian)動(dong)(dong)車(che)(che)(che)(che)(che)核(he)心**糾(jiu)(jiu)(jiu)紛(fen)(fen)(fen)案(an)(an)(an)(an)(an)例(li)1:LG化(hua)(hua)學 vs. SK創(chuang)(chuang)新(xin)(xin)(xin) (2020-2021年(nian)(nian)(nian)(nian)(nian))時(shi)間(jian): 2020年(nian)(nian)(nian)(nian)(nian)-2021年(nian)(nian)(nian)(nian)(nian)爭(zheng)(zheng)(zheng)議(yi)(yi)(yi)領(ling)(ling)(ling)(ling)域(yu): 電(dian)(dian)(dian)(dian)(dian)動(dong)(dong)汽(qi)車(che)(che)(che)(che)(che)電(dian)(dian)(dian)(dian)(dian)池(chi)(chi)(chi)技(ji)(ji)(ji)術(shu)(shu)(shu)(商(shang)(shang)業(ye)秘密(mi)(mi))案(an)(an)(an)(an)(an)情(qing)摘(zhai)(zhai)要(yao): 韓國(guo)(guo)(guo)(guo)兩(liang)大(da)(da)電(dian)(dian)(dian)(dian)(dian)池(chi)(chi)(chi)巨頭(tou)在(zai)(zai)美(mei)國(guo)(guo)(guo)(guo)爆(bao)發(fa)(fa)激烈法(fa)(fa)(fa)(fa)(fa)律(lv)戰(zhan)。LG化(hua)(hua)學(現為(wei)(wei)(wei)(wei)LG能(neng)(neng)源(yuan)(yuan)(yuan)解(jie)決(jue)方(fang)案(an)(an)(an)(an)(an))指(zhi)(zhi)(zhi)控(kong)SK創(chuang)(chuang)新(xin)(xin)(xin)(SK Innovation)通(tong)過(guo)雇傭其(qi)(qi)(qi)(qi)(qi)前(qian)(qian)(qian)員工竊取(qu)了(le)大(da)(da)量與(yu)(yu)(yu)電(dian)(dian)(dian)(dian)(dian)動(dong)(dong)汽(qi)車(che)(che)(che)(che)(che)電(dian)(dian)(dian)(dian)(dian)池(chi)(chi)(chi)技(ji)(ji)(ji)術(shu)(shu)(shu)相(xiang)關(guan)(guan)的(de)(de)(de)(de)(de)(de)(de)(de)商(shang)(shang)業(ye)秘密(mi)(mi),包(bao)(bao)括關(guan)(guan)于鋰(li)電(dian)(dian)(dian)(dian)(dian)池(chi)(chi)(chi)隔膜的(de)(de)(de)(de)(de)(de)(de)(de)關(guan)(guan)鍵(jian)技(ji)(ji)(ji)術(shu)(shu)(shu)。糾(jiu)(jiu)(jiu)紛(fen)(fen)(fen)結(jie)(jie)果: 美(mei)國(guo)(guo)(guo)(guo)國(guo)(guo)(guo)(guo)際(ji)貿易委員會(hui)(ITC)于2021年(nian)(nian)(nian)(nian)(nian)2月(yue)(yue)作(zuo)出(chu)*終裁(cai)決(jue),對(dui)(dui)SK創(chuang)(chuang)新(xin)(xin)(xin)發(fa)(fa)出(chu)為(wei)(wei)(wei)(wei)期(qi)10年(nian)(nian)(nian)(nian)(nian)的(de)(de)(de)(de)(de)(de)(de)(de)禁(jin)止令,禁(jin)止其(qi)(qi)(qi)(qi)(qi)向美(mei)國(guo)(guo)(guo)(guo)進口電(dian)(dian)(dian)(dian)(dian)動(dong)(dong)汽(qi)車(che)(che)(che)(che)(che)電(dian)(dian)(dian)(dian)(dian)池(chi)(chi)(chi)、模塊(kuai)、電(dian)(dian)(dian)(dian)(dian)池(chi)(chi)(chi)包(bao)(bao)及(ji)相(xiang)關(guan)(guan)零(ling)部(bu)件(jian)(jian)(jian)。*終,在(zai)(zai)拜登(deng)政府介入和(he)雙(shuang)(shuang)(shuang)(shuang)方(fang)壓力下(xia),2021年(nian)(nian)(nian)(nian)(nian)4月(yue)(yue),雙(shuang)(shuang)(shuang)(shuang)方(fang)達(da)(da)(da)成(cheng)(cheng)(cheng)(cheng)(cheng)(cheng)(cheng)(cheng)和(he)解(jie)。SK創(chuang)(chuang)新(xin)(xin)(xin)向LG支付(fu)(fu)2萬(wan)(wan)(wan)億韓元(yuan)(yuan)(yuan)(yuan)(約(yue)18億美(mei)元(yuan)(yuan)(yuan)(yuan))的(de)(de)(de)(de)(de)(de)(de)(de)賠(pei)(pei)償金(jin)(包(bao)(bao)括現金(jin)和(he)版稅),并(bing)撤回(hui)相(xiang)關(guan)(guan)訴(su)(su)(su)訟(song)(song)(song)(song)。來(lai)源(yuan)(yuan)(yuan):United States International Trade Commission. (2021). Certain Lithium Ion Batteries, Battery Cells, Battery Modules, Battery Packs, Components Thereof, and Processes Therefor. Investigation No. 337-TA-1159.Reuters. (2021年(nian)(nian)(nian)(nian)(nian)4月(yue)(yue)11日(ri)(ri)(ri)). LG Energy, SK Innovation reach settlement in battery dispute.案(an)(an)(an)(an)(an)例(li)2:寧(ning)德時(shi)代 vs. 中(zhong)(zhong)創(chuang)(chuang)新(xin)(xin)(xin)航 (2022年(nian)(nian)(nian)(nian)(nian)-2023年(nian)(nian)(nian)(nian)(nian))時(shi)間(jian): 2022年(nian)(nian)(nian)(nian)(nian)-2023年(nian)(nian)(nian)(nian)(nian)爭(zheng)(zheng)(zheng)議(yi)(yi)(yi)領(ling)(ling)(ling)(ling)域(yu): 鋰(li)電(dian)(dian)(dian)(dian)(dian)池(chi)(chi)(chi)結(jie)(jie)構技(ji)(ji)(ji)術(shu)(shu)(shu)**(正極(ji)極(ji)片、防爆(bao)閥(fa)等(deng))案(an)(an)(an)(an)(an)情(qing)摘(zhai)(zhai)要(yao): 中(zhong)(zhong)國(guo)(guo)(guo)(guo)動(dong)(dong)力電(dian)(dian)(dian)(dian)(dian)池(chi)(chi)(chi)巨頭(tou)寧(ning)德時(shi)代(CATL)對(dui)(dui)其(qi)(qi)(qi)(qi)(qi)競(jing)(jing)爭(zheng)(zheng)(zheng)對(dui)(dui)手(shou)(shou)中(zhong)(zhong)創(chuang)(chuang)新(xin)(xin)(xin)航(CALB)發(fa)(fa)起(qi)(qi)(qi)(qi)多(duo)(duo)(duo)項(xiang)(xiang)**侵(qin)(qin)權(quan)(quan)(quan)訴(su)(su)(su)訟(song)(song)(song)(song),指(zhi)(zhi)(zhi)控(kong)其(qi)(qi)(qi)(qi)(qi)侵(qin)(qin)犯(fan)了(le)包(bao)(bao)括“正極(ji)極(ji)片及(ji)電(dian)(dian)(dian)(dian)(dian)池(chi)(chi)(chi)”、“防爆(bao)裝置(zhi)”在(zai)(zai)內(nei)的(de)(de)(de)(de)(de)(de)(de)(de)多(duo)(duo)(duo)項(xiang)(xiang)核(he)心**。此(ci)案(an)(an)(an)(an)(an)被視(shi)為(wei)(wei)(wei)(wei)中(zhong)(zhong)國(guo)(guo)(guo)(guo)電(dian)(dian)(dian)(dian)(dian)池(chi)(chi)(chi)行(xing)(xing)(xing)業(ye)史上(shang)*大(da)(da)規模的(de)(de)(de)(de)(de)(de)(de)(de)**戰(zhan)。糾(jiu)(jiu)(jiu)紛(fen)(fen)(fen)結(jie)(jie)果: 經過(guo)多(duo)(duo)(duo)輪庭審,2023年(nian)(nian)(nian)(nian)(nian),福建省(sheng)高(gao)級人民(min)(min)(min)法(fa)(fa)(fa)(fa)(fa)院(yuan)作(zuo)出(chu)終審判(pan)(pan)(pan)(pan)決(jue),裁(cai)定中(zhong)(zhong)創(chuang)(chuang)新(xin)(xin)(xin)航侵(qin)(qin)犯(fan)寧(ning)德時(shi)代兩(liang)項(xiang)(xiang)**,需(xu)立即停止銷(xiao)售侵(qin)(qin)權(quan)(quan)(quan)產(chan)(chan)(chan)(chan)品,并(bing)賠(pei)(pei)償寧(ning)德時(shi)代總(zong)計約(yue)人民(min)(min)(min)幣5700萬(wan)(wan)(wan)元(yuan)(yuan)(yuan)(yuan)的(de)(de)(de)(de)(de)(de)(de)(de)經濟損失。此(ci)外(wai),中(zhong)(zhong)創(chuang)(chuang)新(xin)(xin)(xin)航還被要(yao)求支付(fu)(fu)高(gao)達(da)(da)(da)數百萬(wan)(wan)(wan)元(yuan)(yuan)(yuan)(yuan)的(de)(de)(de)(de)(de)(de)(de)(de)**許(xu)可費(fei)(fei)。來(lai)源(yuan)(yuan)(yuan):福建省(sheng)高(gao)級人民(min)(min)(min)法(fa)(fa)(fa)(fa)(fa)院(yuan) (2023) 閩民(min)(min)(min)終XX號(hao)民(min)(min)(min)事判(pan)(pan)(pan)(pan)決(jue)書(shu)(具體(ti)(ti)案(an)(an)(an)(an)(an)號(hao)因(yin)(yin)公(gong)開信(xin)息省(sheng)略)。第一財經. (2023年(nian)(nian)(nian)(nian)(nian)2月(yue)(yue)21日(ri)(ri)(ri)). 《寧(ning)德時(shi)代與(yu)(yu)(yu)中(zhong)(zhong)創(chuang)(chuang)新(xin)(xin)(xin)航**戰(zhan)落(luo)幕:中(zhong)(zhong)創(chuang)(chuang)新(xin)(xin)(xin)航賠(pei)(pei)償5700萬(wan)(wan)(wan)元(yuan)(yuan)(yuan)(yuan)》。二、 自(zi)動(dong)(dong)駕(jia)(jia)駛(shi)與(yu)(yu)(yu)智能(neng)(neng)網聯技(ji)(ji)(ji)術(shu)(shu)(shu)糾(jiu)(jiu)(jiu)紛(fen)(fen)(fen)案(an)(an)(an)(an)(an)例(li)3:Waymo vs. Uber (2020年(nian)(nian)(nian)(nian)(nian)和(he)解(jie)后(hou)延續(xu)(xu)影(ying)(ying)(ying)響(xiang))時(shi)間(jian): 2017年(nian)(nian)(nian)(nian)(nian)發(fa)(fa)起(qi)(qi)(qi)(qi),2020年(nian)(nian)(nian)(nian)(nian)達(da)(da)(da)成(cheng)(cheng)(cheng)(cheng)(cheng)(cheng)(cheng)(cheng)和(he)解(jie)但(dan)(dan)(dan)影(ying)(ying)(ying)響(xiang)持(chi)續(xu)(xu)。爭(zheng)(zheng)(zheng)議(yi)(yi)(yi)領(ling)(ling)(ling)(ling)域(yu): 激光雷達(da)(da)(da)(LiDAR)和(he)自(zi)動(dong)(dong)駕(jia)(jia)駛(shi)商(shang)(shang)業(ye)秘密(mi)(mi)案(an)(an)(an)(an)(an)情(qing)摘(zhai)(zhai)要(yao): 谷歌(ge)旗下(xia)自(zi)動(dong)(dong)駕(jia)(jia)駛(shi)公(gong)司(si)(si)(si)Waymo指(zhi)(zhi)(zhi)控(kong)其(qi)(qi)(qi)(qi)(qi)前(qian)(qian)(qian)工程(cheng)師Anthony Levandowski在(zai)(zai)離職前(qian)(qian)(qian)下(xia)載(zai)了(le)超過(guo)1.4萬(wan)(wan)(wan)份機(ji)密(mi)(mi)文件(jian)(jian)(jian),并(bing)隨后(hou)創(chuang)(chuang)辦(ban)了(le)自(zi)動(dong)(dong)駕(jia)(jia)駛(shi)卡(ka)(ka)車(che)(che)(che)(che)(che)公(gong)司(si)(si)(si)Otto(后(hou)被Uber收(shou)購),Uber因(yin)(yin)此(ci)使(shi)用(yong)了(le)這(zhe)(zhe)些技(ji)(ji)(ji)術(shu)(shu)(shu)。糾(jiu)(jiu)(jiu)紛(fen)(fen)(fen)結(jie)(jie)果: 雙(shuang)(shuang)(shuang)(shuang)方(fang)于2018年(nian)(nian)(nian)(nian)(nian)達(da)(da)(da)成(cheng)(cheng)(cheng)(cheng)(cheng)(cheng)(cheng)(cheng)和(he)解(jie),但(dan)(dan)(dan)2020年(nian)(nian)(nian)(nian)(nian),該案(an)(an)(an)(an)(an)有(you)(you)了(le)后(hou)續(xu)(xu)進展(zhan)。Anthony Levandowski因(yin)(yin)盜竊商(shang)(shang)業(ye)機(ji)密(mi)(mi)被美(mei)國(guo)(guo)(guo)(guo)法(fa)(fa)(fa)(fa)(fa)院(yuan)判(pan)(pan)(pan)(pan)處18個(ge)月(yue)(yue)監禁(jin)(后(hou)獲特(te)(te)朗普特(te)(te)赦)。此(ci)案(an)(an)(an)(an)(an)確立了(le)自(zi)動(dong)(dong)駕(jia)(jia)駛(shi)領(ling)(ling)(ling)(ling)域(yu)商(shang)(shang)業(ye)秘密(mi)(mi)保(bao)護(hu)的(de)(de)(de)(de)(de)(de)(de)(de)極(ji)端(duan)重(zhong)要(yao)性(xing)(xing),為(wei)(wei)(wei)(wei)后(hou)續(xu)(xu)類似案(an)(an)(an)(an)(an)件(jian)(jian)(jian)提供了(le)判(pan)(pan)(pan)(pan)例(li)。來(lai)源(yuan)(yuan)(yuan):United States District Court, Northern District of California. Case No. 3:17-cv-00939-WHA.The New York Times. (2020年(nian)(nian)(nian)(nian)(nian)8月(yue)(yue)5日(ri)(ri)(ri)). Ex-Google Engineer Avoids Prison After Trump Commutes Sentence.案(an)(an)(an)(an)(an)例(li)4:特(te)(te)斯(si)(si)拉(la) vs. 小(xiao)(xiao)鵬汽(qi)車(che)(che)(che)(che)(che) (2019年(nian)(nian)(nian)(nian)(nian)發(fa)(fa)起(qi)(qi)(qi)(qi),2021年(nian)(nian)(nian)(nian)(nian)和(he)解(jie))時(shi)間(jian): 2019年(nian)(nian)(nian)(nian)(nian)發(fa)(fa)起(qi)(qi)(qi)(qi)訴(su)(su)(su)訟(song)(song)(song)(song),2021年(nian)(nian)(nian)(nian)(nian)4月(yue)(yue)達(da)(da)(da)成(cheng)(cheng)(cheng)(cheng)(cheng)(cheng)(cheng)(cheng)和(he)解(jie)。爭(zheng)(zheng)(zheng)議(yi)(yi)(yi)領(ling)(ling)(ling)(ling)域(yu): 自(zi)動(dong)(dong)駕(jia)(jia)駛(shi)源(yuan)(yuan)(yuan)代碼(ma)與(yu)(yu)(yu)商(shang)(shang)業(ye)秘密(mi)(mi)案(an)(an)(an)(an)(an)情(qing)摘(zhai)(zhai)要(yao): 特(te)(te)斯(si)(si)拉(la)起(qi)(qi)(qi)(qi)訴(su)(su)(su)其(qi)(qi)(qi)(qi)(qi)前(qian)(qian)(qian)華裔工程(cheng)師曹(cao)光植,指(zhi)(zhi)(zhi)控(kong)其(qi)(qi)(qi)(qi)(qi)在(zai)(zai)入職小(xiao)(xiao)鵬汽(qi)車(che)(che)(che)(che)(che)前(qian)(qian)(qian),將特(te)(te)斯(si)(si)拉(la)自(zi)動(dong)(dong)駕(jia)(jia)駛(shi)系統(tong)Autopilot的(de)(de)(de)(de)(de)(de)(de)(de)源(yuan)(yuan)(yuan)代碼(ma)副本(ben)(ben)上(shang)傳(chuan)至其(qi)(qi)(qi)(qi)(qi)個(ge)人iCloud賬(zhang)戶。小(xiao)(xiao)鵬汽(qi)車(che)(che)(che)(che)(che)作(zuo)為(wei)(wei)(wei)(wei)曹(cao)光植的(de)(de)(de)(de)(de)(de)(de)(de)新(xin)(xin)(xin)雇主(zhu)被卷(juan)入訴(su)(su)(su)訟(song)(song)(song)(song)。糾(jiu)(jiu)(jiu)紛(fen)(fen)(fen)結(jie)(jie)果: 經過(guo)長(chang)達(da)(da)(da)兩(liang)年(nian)(nian)(nian)(nian)(nian)的(de)(de)(de)(de)(de)(de)(de)(de)調查(cha)和(he)庭審,雙(shuang)(shuang)(shuang)(shuang)方(fang)于2021年(nian)(nian)(nian)(nian)(nian)4月(yue)(yue)達(da)(da)(da)成(cheng)(cheng)(cheng)(cheng)(cheng)(cheng)(cheng)(cheng)和(he)解(jie)。特(te)(te)斯(si)(si)拉(la)對(dui)(dui)小(xiao)(xiao)鵬汽(qi)車(che)(che)(che)(che)(che)的(de)(de)(de)(de)(de)(de)(de)(de)技(ji)(ji)(ji)術(shu)(shu)(shu)共(gong)享(xiang)請求表(biao)示滿意,并(bing)結(jie)(jie)束了(le)此(ci)案(an)(an)(an)(an)(an)。此(ci)案(an)(an)(an)(an)(an)凸顯(xian)了(le)中(zhong)(zhong)美(mei)科技(ji)(ji)(ji)公(gong)司(si)(si)(si)在(zai)(zai)尖端(duan)技(ji)(ji)(ji)術(shu)(shu)(shu)人才競(jing)(jing)爭(zheng)(zheng)(zheng)中(zhong)(zhong)的(de)(de)(de)(de)(de)(de)(de)(de)IP沖突。來(lai)源(yuan)(yuan)(yuan):United States District Court, Northern District of California. Case No. 3:19-cv-01463-RS.Reuters. (2021年(nian)(nian)(nian)(nian)(nian)4月(yue)(yue)16日(ri)(ri)(ri)). Tesla settles lawsuit against engineer who moved to Xpeng Motors.(預測(ce)) 案(an)(an)(an)(an)(an)例(li)5:某(mou)科技(ji)(ji)(ji)公(gong)司(si)(si)(si) vs. 某(mou)傳(chuan)統(tong)車(che)(che)(che)(che)(che)企(qi)(qi)(qi) (2025年(nian)(nian)(nian)(nian)(nian)預測(ce))時(shi)間(jian): 2025年(nian)(nian)(nian)(nian)(nian)(預測(ce))爭(zheng)(zheng)(zheng)議(yi)(yi)(yi)領(ling)(ling)(ling)(ling)域(yu): 大(da)(da)模型(xing)(xing)(xing)在(zai)(zai)智能(neng)(neng)座(zuo)艙(cang)中(zhong)(zhong)的(de)(de)(de)(de)(de)(de)(de)(de)應(ying)用(yong)**案(an)(an)(an)(an)(an)情(qing)摘(zhai)(zhai)要(yao): 隨著生成(cheng)(cheng)(cheng)(cheng)(cheng)(cheng)(cheng)(cheng)式AI大(da)(da)模型(xing)(xing)(xing)在(zai)(zai)車(che)(che)(che)(che)(che)載(zai)語音助(zhu)手(shou)(shou)、場景化(hua)(hua)服務中(zhong)(zhong)的(de)(de)(de)(de)(de)(de)(de)(de)深(shen)度集成(cheng)(cheng)(cheng)(cheng)(cheng)(cheng)(cheng)(cheng),某(mou)家(jia)專注于AI技(ji)(ji)(ji)術(shu)(shu)(shu)的(de)(de)(de)(de)(de)(de)(de)(de)科技(ji)(ji)(ji)公(gong)司(si)(si)(si)(如已(yi)布局相(xiang)關(guan)(guan)**的(de)(de)(de)(de)(de)(de)(de)(de)百度、谷歌(ge)或(huo)一家(jia)初創(chuang)(chuang)公(gong)司(si)(si)(si))可能(neng)(neng)會(hui)對(dui)(dui)某(mou)家(jia)傳(chuan)統(tong)車(che)(che)(che)(che)(che)企(qi)(qi)(qi)巨頭(tou)發(fa)(fa)起(qi)(qi)(qi)(qi)**侵(qin)(qin)權(quan)(quan)(quan)訴(su)(su)(su)訟(song)(song)(song)(song),指(zhi)(zhi)(zhi)控(kong)其(qi)(qi)(qi)(qi)(qi)智能(neng)(neng)座(zuo)艙(cang)系統(tong)中(zhong)(zhong)的(de)(de)(de)(de)(de)(de)(de)(de)對(dui)(dui)話式AI、個(ge)性(xing)(xing)化(hua)(hua)推薦等(deng)功(gong)能(neng)(neng)侵(qin)(qin)犯(fan)了(le)其(qi)(qi)(qi)(qi)(qi)自(zi)然語言(yan)處理(NLP)和(he)機(ji)器學習模型(xing)(xing)(xing)的(de)(de)(de)(de)(de)(de)(de)(de)**權(quan)(quan)(quan)。潛在(zai)(zai)影(ying)(ying)(ying)響(xiang): 這(zhe)(zhe)類糾(jiu)(jiu)(jiu)紛(fen)(fen)(fen)將把汽(qi)車(che)(che)(che)(che)(che)IP戰(zhan)的(de)(de)(de)(de)(de)(de)(de)(de)戰(zhan)火從硬件(jian)(jian)(jian)、傳(chuan)統(tong)軟(ruan)件(jian)(jian)(jian)引(yin)向AI算(suan)法(fa)(fa)(fa)(fa)(fa)和(he)數據處理層面,可能(neng)(neng)引(yin)發(fa)(fa)一系列(lie)關(guan)(guan)于AI生成(cheng)(cheng)(cheng)(cheng)(cheng)(cheng)(cheng)(cheng)內(nei)容版權(quan)(quan)(quan)和(he)算(suan)法(fa)(fa)(fa)(fa)(fa)**有(you)(you)效性(xing)(xing)的(de)(de)(de)(de)(de)(de)(de)(de)新(xin)(xin)(xin)法(fa)(fa)(fa)(fa)(fa)律(lv)挑戰(zhan)。三(san)、 軟(ruan)件(jian)(jian)(jian)與(yu)(yu)(yu)用(yong)戶界面(UI)設(she)(she)(she)計糾(jiu)(jiu)(jiu)紛(fen)(fen)(fen)案(an)(an)(an)(an)(an)例(li)6:寶馬、奔(ben)馳等(deng) vs. **主(zhu)張(zhang)(zhang)實(shi)(shi)體(ti)(ti)(PAE) (2020年(nian)(nian)(nian)(nian)(nian)至今)時(shi)間(jian): 2020年(nian)(nian)(nian)(nian)(nian)持(chi)續(xu)(xu)至今爭(zheng)(zheng)(zheng)議(yi)(yi)(yi)領(ling)(ling)(ling)(ling)域(yu): 車(che)(che)(che)(che)(che)載(zai)軟(ruan)件(jian)(jian)(jian)、通(tong)信(xin)協(xie)議(yi)(yi)(yi)等(deng)基礎(chu)**案(an)(an)(an)(an)(an)情(qing)摘(zhai)(zhai)要(yao): 多(duo)(duo)(duo)家(jia)汽(qi)車(che)(che)(che)(che)(che)制(zhi)造(zao)商(shang)(shang),包(bao)(bao)括寶馬、奔(ben)馳、大(da)(da)眾等(deng),持(chi)續(xu)(xu)成(cheng)(cheng)(cheng)(cheng)(cheng)(cheng)(cheng)(cheng)為(wei)(wei)(wei)(wei)**主(zhu)張(zhang)(zhang)實(shi)(shi)體(ti)(ti)(Patent Assertion Entities,又稱“**流(liu)氓(mang)”)的(de)(de)(de)(de)(de)(de)(de)(de)目標。這(zhe)(zhe)些PAE大(da)(da)量收(shou)購與(yu)(yu)(yu)3G/4G通(tong)信(xin)、導航軟(ruan)件(jian)(jian)(jian)、車(che)(che)(che)(che)(che)輛遠(yuan)程(cheng)信(xin)息處理等(deng)相(xiang)關(guan)(guan)的(de)(de)(de)(de)(de)(de)(de)(de)基礎(chu)**,然后(hou)向車(che)(che)(che)(che)(che)企(qi)(qi)(qi)發(fa)(fa)起(qi)(qi)(qi)(qi)大(da)(da)規模**侵(qin)(qin)權(quan)(quan)(quan)訴(su)(su)(su)訟(song)(song)(song)(song),尋求高(gao)額(e)許(xu)可費(fei)(fei)或(huo)賠(pei)(pei)償。糾(jiu)(jiu)(jiu)紛(fen)(fen)(fen)結(jie)(jie)果: 這(zhe)(zhe)是(shi)一種持(chi)續(xu)(xu)性(xing)(xing)的(de)(de)(de)(de)(de)(de)(de)(de)行(xing)(xing)(xing)業(ye)現象。車(che)(che)(che)(che)(che)企(qi)(qi)(qi)通(tong)常選擇達(da)(da)(da)成(cheng)(cheng)(cheng)(cheng)(cheng)(cheng)(cheng)(cheng)許(xu)可協(xie)議(yi)(yi)(yi)或(huo)進行(xing)(xing)(xing)法(fa)(fa)(fa)(fa)(fa)庭抗辯(bian)。例(li)如,2021年(nian)(nian)(nian)(nian)(nian),大(da)(da)陸(lu)集團(Continental)在(zai)(zai)美(mei)國(guo)(guo)(guo)(guo)*高(gao)法(fa)(fa)(fa)(fa)(fa)院(yuan)對(dui)(dui)Avanci等(deng)**池(chi)(chi)(chi)發(fa)(fa)起(qi)(qi)(qi)(qi)反壟(long)斷訴(su)(su)(su)訟(song)(song)(song)(song),試(shi)圖遏制(zhi)PAE的(de)(de)(de)(de)(de)(de)(de)(de)行(xing)(xing)(xing)為(wei)(wei)(wei)(wei),但(dan)(dan)(dan)未(wei)能(neng)(neng)成(cheng)(cheng)(cheng)(cheng)(cheng)(cheng)(cheng)(cheng)功(gong)。這(zhe)(zhe)已(yi)成(cheng)(cheng)(cheng)(cheng)(cheng)(cheng)(cheng)(cheng)為(wei)(wei)(wei)(wei)整(zheng)個(ge)汽(qi)車(che)(che)(che)(che)(che)行(xing)(xing)(xing)業(ye)的(de)(de)(de)(de)(de)(de)(de)(de)“隱形成(cheng)(cheng)(cheng)(cheng)(cheng)(cheng)(cheng)(cheng)本(ben)(ben)”。來(lai)源(yuan)(yuan)(yuan):Juve Patent. (2021年(nian)(nian)(nian)(nian)(nian)多(duo)(duo)(duo)次報道). Avanci, Nokia lawsuits against Daimler and its suppliers.IAM Media. (2022年(nian)(nian)(nian)(nian)(nian)5月(yue)(yue)10日(ri)(ri)(ri)). The auto sector’s PAE problem is not going away.四、 設(she)(she)(she)計與(yu)(yu)(yu)商(shang)(shang)標糾(jiu)(jiu)(jiu)紛(fen)(fen)(fen)案(an)(an)(an)(an)(an)例(li)7:捷(jie)(jie)豹路虎 vs. 江鈴(ling)汽(qi)車(che)(che)(che)(che)(che) (2020年(nian)(nian)(nian)(nian)(nian))時(shi)間(jian): 2020年(nian)(nian)(nian)(nian)(nian)爭(zheng)(zheng)(zheng)議(yi)(yi)(yi)領(ling)(ling)(ling)(ling)域(yu): 車(che)(che)(che)(che)(che)型(xing)(xing)(xing)外(wai)觀設(she)(she)(she)計案(an)(an)(an)(an)(an)情(qing)摘(zhai)(zhai)要(yao): 捷(jie)(jie)豹路虎(JLR)在(zai)(zai)中(zhong)(zhong)國(guo)(guo)(guo)(guo)起(qi)(qi)(qi)(qi)訴(su)(su)(su)江鈴(ling)汽(qi)車(che)(che)(che)(che)(che),指(zhi)(zhi)(zhi)控(kong)其(qi)(qi)(qi)(qi)(qi)生產(chan)(chan)(chan)(chan)的(de)(de)(de)(de)(de)(de)(de)(de)陸(lu)風X7車(che)(che)(che)(che)(che)型(xing)(xing)(xing)的(de)(de)(de)(de)(de)(de)(de)(de)外(wai)觀設(she)(she)(she)計抄襲了(le)路虎攬勝(sheng)極(ji)光(Range Rover Evoque)的(de)(de)(de)(de)(de)(de)(de)(de)獨特(te)(te)設(she)(she)(she)計。糾(jiu)(jiu)(jiu)紛(fen)(fen)(fen)結(jie)(jie)果: 北(bei)京市朝陽(yang)區(qu)人民(min)(min)(min)法(fa)(fa)(fa)(fa)(fa)院(yuan)判(pan)(pan)(pan)(pan)決(jue)捷(jie)(jie)豹路虎勝(sheng)訴(su)(su)(su)。法(fa)(fa)(fa)(fa)(fa)院(yuan)裁(cai)定江鈴(ling)汽(qi)車(che)(che)(che)(che)(che)必須(xu)立即停止陸(lu)風X7的(de)(de)(de)(de)(de)(de)(de)(de)所有(you)(you)銷(xiao)售、制(zhi)造(zao)和(he)營銷(xiao)行(xing)(xing)(xing)為(wei)(wei)(wei)(wei),并(bing)向捷(jie)(jie)豹路虎支付(fu)(fu)賠(pei)(pei)償金(jin)。此(ci)案(an)(an)(an)(an)(an)是(shi)中(zhong)(zhong)國(guo)(guo)(guo)(guo)法(fa)(fa)(fa)(fa)(fa)院(yuan)保(bao)護(hu)外(wai)資企(qi)(qi)(qi)業(ye)外(wai)觀設(she)(she)(she)計產(chan)(chan)(chan)(chan)權(quan)(quan)(quan)的(de)(de)(de)(de)(de)(de)(de)(de)標志性(xing)(xing)案(an)(an)(an)(an)(an)例(li)。來(lai)源(yuan)(yuan)(yuan):北(bei)京市朝陽(yang)區(qu)人民(min)(min)(min)法(fa)(fa)(fa)(fa)(fa)院(yuan) (2019) 京0105民(min)(min)(min)初XX號(hao)民(min)(min)(min)事判(pan)(pan)(pan)(pan)決(jue)書(shu)。BBC News. (2020年(nian)(nian)(nian)(nian)(nian)3月(yue)(yue)26日(ri)(ri)(ri)). Jaguar Land Rover wins Chinese copycat case.(預測(ce)) 案(an)(an)(an)(an)(an)例(li)8:Cybertruck設(she)(she)(she)計元(yuan)(yuan)(yuan)(yuan)素爭(zheng)(zheng)(zheng)議(yi)(yi)(yi) (2024-2025年(nian)(nian)(nian)(nian)(nian)預測(ce))時(shi)間(jian): 2024年(nian)(nian)(nian)(nian)(nian)末-2025年(nian)(nian)(nian)(nian)(nian)(預測(ce))爭(zheng)(zheng)(zheng)議(yi)(yi)(yi)領(ling)(ling)(ling)(ling)域(yu): 標志性(xing)(xing)外(wai)觀設(she)(she)(she)計案(an)(an)(an)(an)(an)情(qing)摘(zhai)(zhai)要(yao): 隨著特(te)(te)斯(si)(si)拉(la)Cybertruck的(de)(de)(de)(de)(de)(de)(de)(de)正式交付(fu)(fu)和(he)其(qi)(qi)(qi)(qi)(qi)**未(wei)來(lai)感(gan)的(de)(de)(de)(de)(de)(de)(de)(de)棱角(jiao)設(she)(she)(she)計成(cheng)(cheng)(cheng)(cheng)(cheng)(cheng)(cheng)(cheng)為(wei)(wei)(wei)(wei)標志,其(qi)(qi)(qi)(qi)(qi)他車(che)(che)(che)(che)(che)企(qi)(qi)(qi)(尤(you)其(qi)(qi)(qi)(qi)(qi)是(shi)新(xin)(xin)(xin)興電(dian)(dian)(dian)(dian)(dian)動(dong)(dong)車(che)(che)(che)(che)(che)品牌(pai)或(huo)小(xiao)(xiao)眾制(zhi)造(zao)商(shang)(shang))若(ruo)推出(chu)類似棱角(jiao)分明的(de)(de)(de)(de)(de)(de)(de)(de)皮卡(ka)(ka)或(huo)SUV車(che)(che)(che)(che)(che)型(xing)(xing)(xing),特(te)(te)斯(si)(si)拉(la)可能(neng)(neng)會(hui)采(cai)取(qu)強硬的(de)(de)(de)(de)(de)(de)(de)(de)法(fa)(fa)(fa)(fa)(fa)律(lv)行(xing)(xing)(xing)動(dong)(dong),主(zhu)張(zhang)(zhang)其(qi)(qi)(qi)(qi)(qi)獨特(te)(te)的(de)(de)(de)(de)(de)(de)(de)(de)設(she)(she)(she)計語言(yan)受保(bao)護(hu),從而引(yin)發(fa)(fa)新(xin)(xin)(xin)的(de)(de)(de)(de)(de)(de)(de)(de)設(she)(she)(she)計**糾(jiu)(jiu)(jiu)紛(fen)(fen)(fen)。潛在(zai)(zai)影(ying)(ying)(ying)響(xiang): 這(zhe)(zhe)將測(ce)試(shi)汽(qi)車(che)(che)(che)(che)(che)設(she)(she)(she)計**在(zai)(zai)“非傳(chuan)統(tong)”造(zao)型(xing)(xing)(xing)上(shang)的(de)(de)(de)(de)(de)(de)(de)(de)保(bao)護(hu)范(fan)圍。總(zong)結(jie)(jie)與(yu)(yu)(yu)趨(qu)勢分析主(zhu)戰(zhan)場轉移: 從傳(chuan)統(tong)內(nei)燃機(ji)技(ji)(ji)(ji)術(shu)(shu)(shu)全(quan)(quan)面轉向電(dian)(dian)(dian)(dian)(dian)池(chi)(chi)(chi)、電(dian)(dian)(dian)(dian)(dian)驅、電(dian)(dian)(dian)(dian)(dian)控(kong)、智能(neng)(neng)座(zuo)艙(cang)和(he)自(zi)動(dong)(dong)駕(jia)(jia)駛(shi)軟(ruan)件(jian)(jian)(jian)算(suan)法(fa)(fa)(fa)(fa)(fa)。爭(zheng)(zheng)(zheng)議(yi)(yi)(yi)類型(xing)(xing)(xing)多(duo)(duo)(duo)樣化(hua)(hua): 從**侵(qin)(qin)權(quan)(quan)(quan)擴展(zhan)到商(shang)(shang)業(ye)秘密(mi)(mi)盜竊、軟(ruan)件(jian)(jian)(jian)著作(zuo)權(quan)(quan)(quan)、UI/UX設(she)(she)(she)計**以及(ji)標準必要(yao)**(SEP)許(xu)可費(fei)(fei)糾(jiu)(jiu)(jiu)紛(fen)(fen)(fen)。主(zhu)體(ti)(ti)多(duo)(duo)(duo)元(yuan)(yuan)(yuan)(yuan)化(hua)(hua): 參與(yu)(yu)(yu)方(fang)不再僅(jin)是(shi)車(che)(che)(che)(che)(che)企(qi)(qi)(qi),科技(ji)(ji)(ji)公(gong)司(si)(si)(si)、零(ling)部(bu)件(jian)(jian)(jian)供應(ying)商(shang)(shang)、電(dian)(dian)(dian)(dian)(dian)池(chi)(chi)(chi)制(zhi)造(zao)商(shang)(shang)、**運營實(shi)(shi)體(ti)(ti)(NPEs/PAEs) 都深(shen)度參與(yu)(yu)(yu)其(qi)(qi)(qi)(qi)(qi)中(zhong)(zhong)。地域(yu)全(quan)(quan)球化(hua)(hua): 中(zhong)(zhong)美(mei)歐成(cheng)(cheng)(cheng)(cheng)(cheng)(cheng)(cheng)(cheng)為(wei)(wei)(wei)(wei)*主(zhu)要(yao)的(de)(de)(de)(de)(de)(de)(de)(de)IP糾(jiu)(jiu)(jiu)紛(fen)(fen)(fen)戰(zhan)場,尤(you)其(qi)(qi)(qi)(qi)(qi)是(shi)中(zhong)(zhong)國(guo)(guo)(guo)(guo),隨著本(ben)(ben)土車(che)(che)(che)(che)(che)企(qi)(qi)(qi)和(he)技(ji)(ji)(ji)術(shu)(shu)(shu)公(gong)司(si)(si)(si)的(de)(de)(de)(de)(de)(de)(de)(de)崛起(qi)(qi)(qi)(qi),其(qi)(qi)(qi)(qi)(qi)國(guo)(guo)(guo)(guo)內(nei)和(he)國(guo)(guo)(guo)(guo)際(ji)IP訴(su)(su)(su)訟(song)(song)(song)(song)活動(dong)(dong)顯(xian)著增加。和(he)解(jie)成(cheng)(cheng)(cheng)(cheng)(cheng)(cheng)(cheng)(cheng)為(wei)(wei)(wei)(wei)常態: 鑒于訴(su)(su)(su)訟(song)(song)(song)(song)成(cheng)(cheng)(cheng)(cheng)(cheng)(cheng)(cheng)(cheng)本(ben)(ben)高(gao)昂、技(ji)(ji)(ji)術(shu)(shu)(shu)復雜性(xing)(xing)高(gao)且可能(neng)(neng)影(ying)(ying)(ying)響(xiang)供應(ying)鏈,許(xu)多(duo)(duo)(duo)案(an)(an)(an)(an)(an)例(li)*終以和(he)解(jie)和(he)交叉許(xu)可告終,但(dan)(dan)(dan)前(qian)(qian)(qian)提是(shi)雙(shuang)(shuang)(shuang)(shuang)方(fang)實(shi)(shi)力對(dui)(dui)等(deng)。說明: 2025年(nian)(nian)(nian)(nian)(nian)的(de)(de)(de)(de)(de)(de)(de)(de)案(an)(an)(an)(an)(an)例(li)基于當(dang)前(qian)(qian)(qian)行(xing)(xing)(xing)業(ye)動(dong)(dong)態和(he)技(ji)(ji)(ji)術(shu)(shu)(shu)發(fa)(fa)展(zhan)趨(qu)勢進行(xing)(xing)(xing)的(de)(de)(de)(de)(de)(de)(de)(de)合(he)理預測(ce),旨在(zai)(zai)提供前(qian)(qian)(qian)瞻性(xing)(xing)視(shi)角(jiao)。實(shi)(shi)際(ji)發(fa)(fa)生的(de)(de)(de)(de)(de)(de)(de)(de)事件(jian)(jian)(jian)請以未(wei)來(lai)官方(fang)發(fa)(fa)布的(de)(de)(de)(de)(de)(de)(de)(de)信(xin)息為(wei)(wei)(wei)(wei)準。Ann Tel: +86 021-60778889- 808新(xin)(xin)(xin)能(neng)(neng)源(yuan)(yuan)(yuan)與(yu)(yu)(yu)智能(neng)(neng)網聯汽(qi)車(che)(che)(che)(che)(che)知識產(chan)(chan)(chan)(chan)權(quan)(quan)(quan)創(chuang)(chuang)新(xin)(xin)(xin)峰會(hui)2025組委會(hui)2025 NEV & ICV IP Innovation Summit//zvuaz.cn/p/554988